Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Dec 1, 2025
Reporting period
Not applicable
Filed with the SEC
Jan 13, 2026
CFOOption exercise
Context
Classification
option exercise
Code M — exercise or conversion of a derivative security
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001193125-26-011926
Filed / recorded
Jan 13, 2026, 10:40 PM UTC
Added to OQRO
Oct 6, 2026, 7:37 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
GLOBUS MEDICAL INC
Issuer CIK
1237831
Ticker
GMED
Reporting person
Kyle Kline
Relationship
Officer
Officer title
Senior Vice President, CFO
Security
Stock Option (Right to Buy Class A Common Stock)
Table
Derivative (Table II)
Transaction date
Dec 1, 2025
Transaction code
M
Shares / units
4,896
Price per share
$0.00
Acquired / disposed
Disposed (D)
Shares owned after
104
Ownership form
Direct
Amendment
Yes (Form 4/A)
Footnotes from the filing
On December 3, 2025, the reporting person filed a Form 4 which inadvertently reported in Table II that 5,000 options were exercised prior to the sale of the underlying 4,896 shares of the issuer's Class A Common Stock that was reported in Table I. As correctly reported in this amendment, the reporting person exercised 4,896 options prior to the sale of the underlying 4,896 shares of the issuer's Class A Common Stock.
These options were granted on January 27, 2022, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2023, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.